The ABCs (Antibody, B Cells, and Carbohydrate Epitopes) of Cholera Immunity: Considerations for an Improved Vaccine

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Microbiology and immunology

• Publication date

  2006-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1348-0421.2006.tb03866.xPMID 17179659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunogenicity of synthetic saccharide fragments of Vibrio cholerae O1 (Ogawa and Inaba) bound to Exotoxin A.

  2006cited by this paper
• How antibodies act as natural adjuvants.

  2006cited by this paper
• Phenotypic and functional characterization of human CD25+ B cells

  2006cited by this paper
• Subclass distribution of natural salivary IgA antibodies against pneumococcal capsular polysaccharide of type 14 and pneumococcal surface adhesin A (PsaA) in children

  2006cited by this paper
• The Radioprotective 105/MD-1 Complex Links TLR2 and TLR4/MD-2 in Antibody Response to Microbial Membranes1

  2005cited by this paper
• Refractory periods and climate forcing in cholera dynamics

  2005cited by this paper
• Clearance of Bordetella parapertussis from the Lower Respiratory Tract Requires Humoral and Cellular Immunity

  2005cited by this paper
• Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response.

  2005cited by this paper
• The unresponsiveness of aged mice to polysaccharide antigens is a result of a defect in macrophage function

  2005cited by this paper
• Peptides mimicking Vibrio cholerae O139 capsular polysaccharide elicit protective antibody response.

  2005cited by this paper
• Lipopolysaccharides from Vibrio cholerae

  2005cited by this paper
• CD27+ B cells in human lymphatic organs: re‐evaluating the splenic marginal zone

  2005cited by this paper
• Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh.

  2005cited by this paper
• Expression of toll-like receptors on B lymphocytes.

  2005cited by this paper
• The Complex Mechanism of Antibody-Mediated Clearance of Bordetella from the Lungs Requires TLR41

  2005cited by this paper
• Immune Response to Pneumococcal Polysaccharides 4 and 14 in Elderly and Young Adults: Analysis of the Variable Light Chain Repertoire

  2005cited by this paper
• Blood Group, Immunity, and Risk of Infection with Vibrio cholerae in an Area of Endemicity

  2005cited by this paper
• B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae.

  2005cited by this paper
• Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens.

  2005cited by this paper
• Self-limiting nature of seasonal cholera epidemics: Role of host-mediated amplification of phage

  2005cited by this paper
• Effect of saccharide length on the immunogenicity of neoglycoconjugates from synthetic fragments of the O-SP of Vibrio cholerae O1, serotype Ogawa.

  2005cited by this paper
• IgM: Mucosal response in acute diarrhoeal disease of infants

  2005cited by this paper
• Innate-like B cells

  2005cited by this paper
• Lamina propria dendritic cells in the physiology and pathology of the gastrointestinal tract

  2005cited by this paper
• Vaccine‐induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies

  2005cited by this paper
• Effectiveness of mass oral cholera vaccination in Beira, Mozambique.

  2005cited by this paper
• TcpF Is a Soluble Colonization Factor and Protective Antigen Secreted by El Tor and Classical O1 and O139 Vibrio cholerae Serogroups

  2005cited by this paper
• Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis.

  2005cited by this paper
• Mechanisms underlying the effects of LPS and activation-induced cytidine deaminase on IgA isotype expression.

  2005cited by this paper
• Complement Component C3d-Antigen Complexes Can Either Augment or Inhibit B Lymphocyte Activation and Humoral Immunity in Mice Depending on the Degree of CD21/CD19 Complex Engagement1

  2005cited by this paper
• Human intestinal IgA response is generated in the organized gut-associated lymphoid tissue but not in the lamina propria.

  2005cited by this paper
• Signaling in B cells via Toll-like receptors.

  2005cited by this paper
• IgM Accelerates Affinity Maturation

  2005cited by this paper
• This information is current as Signaling Pathway without Engagement of an Inhibitory Using Its Natural Ligand C 3 dg : Activation Complement Receptor Type 2 ( CR 2 / CD 21 ) Coligation of the B Cell Receptor with

  2005cited by this paper
• Immune Response to Pneumococcal Polysaccharides 4 and 14 in Elderly and Young Adults: Analysis of the Variable Heavy Chain Repertoire

  2005cited by this paper
• Haemophilus influenzae type b conjugate vaccines

  2004cited by this paper
• Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia.

  2004cited by this paper
• Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire.

  2004cited by this paper
• Induction of Interleukin-8 in T84 Cells by Vibrio cholerae

  2004cited by this paper
• Isolated Lymphoid Follicles Can Function as Sites for Induction of Mucosal Immune Responses

  2004cited by this paper
• Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways.

  2004cited by this paper
• The complement system in regulation of adaptive immunity

  2004cited by this paper
• Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens

  2004cited by this paper
• Human Memory B Cells Transferred by Allogenic Bone Marrow Transplantation Contribute Significantly to the Antibody Repertoire of the Recipient 1

  2004cited by this paper
• Gender, age and seasonal effects on IgA deficiency: a study of 7293 Caucasians

  2004cited by this paper
• Somatic Hypermutation and Diverse Immunoglobulin Gene Usage in the Human Antibody Response to the Capsular Polysaccharide of Streptococcus pneumoniae Type 6B

  2004cited by this paper
• B1b lymphocytes confer T cell-independent long-lasting immunity.

  2004cited by this paper
• A Vibrio cholerae Classical TcpA Amino Acid Sequence Induces Protective Antibody That Binds an Area Hypothesized To Be Important for Toxin-Coregulated Pilus Structure

  2004cited by this paper
• Can oral cholera vaccination play a role in controlling a cholera outbreak?

  2004cited by this paper
• Development and selection of marginal zone B cells

  2004cited by this paper
• The CD5+ B-cell.

  2004cited by this paper
• Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells.

  2004cited by this paper
• Progress towards Development of a Cholera Subunit Vaccine

  2004cited by this paper
• Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.

  2004cited by this paper
• Marginal Zone, but Not Follicular B Cells, Are Potent Activators of Naive CD4 T Cells1

  2004cited by this paper
• Age-dependent development of the splenic marginal zone in human infants is associated with different causes of death.

  2004cited by this paper
• Synthetic Fragments of Vibrio cholerae O1 Inaba O-Specific Polysaccharide Bound to a Protein Carrier Are Immunogenic in Mice but Do Not Induce Protective Antibodies

  2004cited by this paper
• Classification of B-cells according to their differentiation status, their micro-anatomical localisation and their developmental lineage.

  2003cited by this paper
• Lipopolysaccharides of Vibrio cholerae. I. Physical and chemical characterization.

  2003cited by this paper
• A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells.

  2003cited by this paper
• Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations

  2003cited by this paper
• The CD40-CD154 interaction in B cell-T cell liaisons.

  2003cited by this paper
• Protective Immunity of Pneumococcal Glycoconjugates

  2003cited by this paper
• Activation and suppression of the proinflammatory immune response by Vibrio cholerae toxins.

  2003cited by this paper
• Antigen-Specific Immunoglobulin A Antibodies Secreted from Circulating B Cells Are an Effective Marker for Recent Local Immune Responses in Patients with Cholera: Comparison to Antibody-Secreting Cell Responses and Other Immunological Markers

  2003cited by this paper
• CpG DNA, liposome and refined antigen oral cholera vaccine.

  2003cited by this paper
• Germline antibody recognition of distinct carbohydrate epitopes

  2003cited by this paper
• The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells.

  2003cited by this paper
• CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes.

  2003cited by this paper
• Novel synthetic LPS receptor agonists boost systemic and mucosal antibody responses in mice.

  2003cited by this paper
• Human secretory immunoglobulin A may contribute to biofilm formation in the gut

  2003cited by this paper
• Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut

  2003cited by this paper
• A simple and convenient microtiter plate assay for the detection of bactericidal antibodies to Vibrio cholerae O1 and Vibrio cholerae O139.

  2003cited by this paper
• Production and characterization of monoclonal antibodies to E1 Tor toxin co-regulated pilus of Vibrio cholerae.

  2003cited by this paper
• Role of secretory antibodies in the defence against infections.

  2003cited by this paper
• Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine.

  2003cited by this paper
• Origins and functions of B-1 cells with notes on the role of CD5.

  2002cited by this paper
• Home-grown Vietnamese cholera vaccine "completely safe".

  2002cited by this paper
• The dual function of the splenic marginal zone: essential for initiation of anti‐TI‐2 responses but also vital in the general first‐line defense against blood‐borne antigens

  2002cited by this paper
• Increased Levels of Inflammatory Mediators in Children and Adults Infected with Vibrio cholerae O1 and O139

  2002cited by this paper
• CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity.

  2002cited by this paper
• Induction of protective immunity by synthetic Vibrio cholerae hexasaccharide derived from V. cholerae O1 Ogawa lipopolysaccharide bound to a protein carrier.

  2002cited by this paper
• Peyer’s Patches: Organized Lymphoid Structures for the Induction of Mucosal Immune Responses in the Intestine

  2002cited by this paper
• Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.

  2002cited by this paper
• Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide.

  2002cited by this paper
• Structural and functional analyses of bacterial lipopolysaccharides.

  2002cited by this paper
• Quorum-sensing regulators control virulence gene expression in Vibrio cholerae

  2002cited by this paper
• Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children.

  2002cited by this paper
• Humoral immunity and long-lived plasma cells.

  2002cited by this paper
• The binding of synthetic analogs of the upstream, terminal residue of the O-polysaccharides (O-PS) of Vibrio cholerae O:1 serotypes Ogawa and Inaba to two murine monoclonal antibodies (MAbs) specific for the Ogawa lipopolysaccharide (LPS).

  2002cited by this paper
• Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens.

  2001cited by this paper
• New developments in the Understanding of cholera

  2001cited by this paper
• Preparation, Immunogenicity, and Protective Efficacy, in a Murine Model, of a Conjugate Vaccine Composed of the Polysaccharide Moiety of the Lipopolysaccharide of Vibrio cholerae O139 Bound to Tetanus Toxoid

  2001cited by this paper
• Fc Receptor-Mediated Immunity Against Bordetella pertussis1

  2001cited by this paper
• CD27 expression in the human splenic marginal zone: the infant marginal zone is populated by naive B cells.

  2001cited by this paper
• Regulation of antigen receptor gene assembly in lymphocytes

  2001cited by this paper
• Characterization of Vibrio cholerae O1 El TorgalU and galE Mutants: Influence on Lipopolysaccharide Structure, Colonization, and Biofilm Formation

  2001cited by this paper
• Safety and Immunogenicity of a Proteosome-Shigella flexneri 2a Lipopolysaccharide Vaccine Administered Intranasally to Healthy Adults

  2001cited by this paper
• Human Infection with Ascaris lumbricoides Is Associated with Suppression of the Interleukin-2 Response to Recombinant Cholera Toxin B Subunit following Vaccination with the Live Oral Cholera Vaccine CVD 103-HgR

  2001cited by this paper
• Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area.

  2000cited by this paper

• B-Cell Epitope Mapping of the Vibrio cholera Toxins A, B, and P and an ELISA Assay

  2022cites this paper
• Long-term sialidase-specific immune responses after natural infection with cholera: Findings from a longitudinal cohort study in Bangladesh

  2022cites this paper
• Antibody-Dependent Enhancement of Bacterial Disease: Prevalence, Mechanisms, and Treatment

  2021cites this paper
• Immunomodulatory effects of mesenchymal stem cell-conditioned media on lipopolysaccharide of Vibrio cholerae as a vaccine candidate

  2021cites this paper
• IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity

  2019cites this paper
• Serum Anti-Vibrio cholerae Immunoglobulin Isotype in BALB/c Mice Immunized With ompW-Loaded Chitosan

  2016cites this paper
• Evaluación en modelos animales de cepas vivas atenuadas de vibrio cholerae O139

  2015cites this paper
• Herbal Compounds-An Alternative for Multi-Drug Resistant Vibrio Cholerae

  2015cites this paper
• Characterization of the immune response to vibrio cholerae O1 antigens and its impact on vaccine development strategies

  2014cites this paper
• Immune response of oral cholera vaccine, Shanchol in Bangladeshi recipients

  2014cites this paper
• Cellulose acetate phthalate microparticles containing Vibrio cholerae: steps toward an oral cholera vaccine

  2014influential citation
• An approach to a cold chain free oral cholera vaccine: in vitro and in vivo characterization of Vibrio cholerae gastro-resistant microparticles.

  2013cites this paper
• Evaluation of enteric-coated tablets as a whole cell inactivated vaccine candidate against Vibrio cholerae.

  2013cites this paper
• Lipopolysaccharide Modifications of a Cholera Vaccine Candidate Based on Outer Membrane Vesicles Reduce Endotoxicity and Reveal the Major Protective Antigen

  2013cites this paper
• vesicles reduce the endotoxicity and reveal the major protective antigen

  2013cites this paper
• Characterization of a Vibrio cholerae Type VI Secretion System Toxin/Immunity Pair

  2013cites this paper
• Ensayo bactericida del suero para la evaluación de la respuesta inmune inducida por vacunas antimeningocócicas y anticoléricas

  2012cites this paper
• Constitutive Type VI Secretion System Expression Gives Vibrio cholerae Intra- and Interspecific Competitive Advantages

  2012cites this paper
• Anti-bacterial and anti-toxic immunity induced by a killed whole-cell-cholera toxin B subunit cholera vaccine is essential for protection against lethal bacterial infection in mouse pulmonary cholera model

  2012cites this paper
• Immunomodulation of T-cell responses with Vibrio cholerae O135 capsular polysaccharide and its protein conjugate, novel cholera vaccine study models.

  2012cites this paper
• Genomic correlates of variability in immune response to an oral cholera vaccine

  2012cites this paper
• A one dose experimental cholera vaccine.

  2012cites this paper
• Multidisciplinary Approaches to Study O-Antigen: Antibody Recognition in Support of the Development of Synthetic Carbohydrate-Based Enteric Vaccines

  2012cites this paper
• Comparison of Immune Responses to the O-Specific Polysaccharide and Lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi Adult Patients with Cholera

  2012cites this paper
• Antibiotic resistance mechanisms of Vibrio cholerae.

  2011cites this paper
• A new oral vaccine candidate based on the microencapsulation by spray-drying of inactivated Vibrio cholerae.

  2011cites this paper
• Molecular analysis of carbohydrate-antibody interactions: case study using a Bacillus anthracis tetrasaccharide.

  2010cites this paper
• Ligand identification of carbohydrate-binding proteins employing a biotinylated glycan binding assay and tandem mass spectrometry.

  2010cites this paper
• Immunomodulative properties of conjugates composed of detoxified lipopolysaccharide and capsular polysaccharide of Vibrio cholerae O135 bound to BSA-protein carrier

  2010cites this paper
• The Immunological Basis for Immunization Series Module 14 : Cholera

  2010cites this paper
• Antigenicidad e inmunogenicidad de una cepa inactivada de Vibrio cholerae O1 El Tor Inaba

  2009cites this paper
• determinant common to Ogawa and Inaba serotypes of Vibrio cholerae O1

  2009cites this paper
• One-Step Immunochromatographic Dipstick Test for Rapid Detection of Vibrio cholerae O1 in Stool Samples

  2009cites this paper
• Variable gene family usage of protective and non‐protective anti‐Vibrio cholerae O1 LPS antibody heavy chains

  2008cites this paper
• Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba

  2008cites this paper
• Development of Peptide Mimics of a Protective Epitope of Vibrio cholerae Ogawa O-antigen and Investigation of the Structural Basis of Peptide Mimicry*

  2007cites this paper
• Crystal structure of a monoclonal antibody directed against an antigenic determinant common to Ogawa and Inaba serotypes of Vibrio cholerae O1

  2007cites this paper